$1.41 Billion is the total value of Eversept Partners, LP's 77 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 59.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| SPY | New | SPDR S&P 500 ETF TRput | $175,421,250 | – | 465,000 | +100.0% | 12.47% | – |
| BHVN | Sell | BIOHAVEN PHARMACTL HLDG CO L | $92,204,414 | +20.6% | 632,794 | -1.8% | 6.56% | +11.7% |
| QQQ | Buy | INVESCO QQQ TRput | $75,675,600 | +16.0% | 270,000 | +50.0% | 5.38% | +7.4% |
| UTHR | Buy | UNITED THERAPEUTICS CORP DEL | $73,244,924 | +39.7% | 310,834 | +6.4% | 5.21% | +29.3% |
| HZNP | Buy | HORIZON THERAPEUTICS PUB L | $70,953,140 | +10.6% | 889,583 | +45.8% | 5.04% | +2.4% |
| GSK | Buy | GSK PLCsponsored adr | $69,912,586 | +25.9% | 1,594,121 | +26.6% | 4.97% | +16.6% |
| GSK | GSK PLCcall | $67,632,561 | -0.1% | 1,553,700 | 0.0% | 4.81% | -7.5% | |
| AZN | Buy | ASTRAZENECA PLCsponsored adr | $67,413,137 | +36.4% | 1,020,329 | +36.9% | 4.79% | +26.3% |
| DHR | Buy | DANAHER CORPORATION | $45,591,592 | -2.8% | 179,659 | +12.4% | 3.24% | -10.0% |
| SNY | New | SANOFIsponsored adr | $43,999,384 | – | 879,460 | +100.0% | 3.13% | – |
| AVTR | Buy | AVANTOR INC | $34,837,443 | +3.5% | 1,120,175 | +12.6% | 2.48% | -4.2% |
| TEVA | Buy | TEVA PHARMACEUTICAL INDS LTDsponsored ads | $33,920,479 | -12.8% | 4,510,702 | +8.9% | 2.41% | -19.3% |
| CYH | Buy | COMMUNITY HEALTH SYS INC NEW | $30,228,221 | -64.3% | 8,060,859 | +13.1% | 2.15% | -66.9% |
| XBI | New | SPDR SER TRs&p biotech | $26,445,096 | – | 356,067 | +100.0% | 1.88% | – |
| NVST | Buy | ENVISTA HOLDINGS CORPORATION | $25,401,483 | -8.4% | 659,094 | +15.8% | 1.81% | -15.2% |
| BIIB | Buy | BIOGEN INC | $20,682,371 | +25.9% | 101,414 | +30.0% | 1.47% | +16.6% |
| ANTM | Buy | ELEVANCE HEALTH INC | $20,647,185 | +29.5% | 42,785 | +31.8% | 1.47% | +19.9% |
| AZN | Sell | ASTRAZENECA PLCcall | $19,840,821 | -47.7% | 300,300 | -47.5% | 1.41% | -51.6% |
| AMRN | Buy | AMARIN CORP PLCspons adr new | $19,794,492 | -33.0% | 13,284,894 | +47.9% | 1.41% | -38.0% |
| CNC | Buy | CENTENE CORP DEL | $19,768,873 | +97.0% | 233,647 | +96.1% | 1.40% | +82.5% |
| XBI | New | SPDR SER TRcall | $19,295,346 | – | 259,800 | +100.0% | 1.37% | – |
| SNDX | New | SYNDAX PHARMACEUTICALS INC | $19,131,525 | – | 994,362 | +100.0% | 1.36% | – |
| ARGX | Buy | ARGENX SEsponsored adr | $18,616,648 | +155.1% | 49,136 | +112.3% | 1.32% | +136.4% |
| FATE | Buy | FATE THERAPEUTICS INC | $18,004,801 | +1.8% | 726,586 | +59.3% | 1.28% | -5.7% |
| AMRX | Buy | AMNEAL PHARMACEUTICALS INC | $17,471,810 | -23.7% | 5,494,280 | +0.1% | 1.24% | -29.4% |
| ABMD | New | ABIOMED INC | $17,151,700 | – | 69,297 | +100.0% | 1.22% | – |
| NTRA | New | NATERA INC | $16,857,213 | – | 475,655 | +100.0% | 1.20% | – |
| GH | Buy | GUARDANT HEALTH INC | $16,393,168 | +16.1% | 406,375 | +90.6% | 1.16% | +7.5% |
| TNDM | New | TANDEM DIABETES CARE INC | $15,168,503 | – | 256,268 | +100.0% | 1.08% | – |
| CLDX | Sell | CELLDEX THERAPEUTICS INC NEW | $14,892,380 | -31.3% | 552,388 | -13.2% | 1.06% | -36.4% |
| XENE | Buy | XENON PHARMACEUTICALS INC | $14,173,013 | +13.1% | 465,911 | +13.6% | 1.01% | +4.8% |
| New | R1 RCM INCco | $12,383,566 | – | 590,819 | +100.0% | 0.88% | – | |
| MRVI | New | MARAVAI LIFESCIENCES HLDGS I | $12,084,591 | – | 425,364 | +100.0% | 0.86% | – |
| LNTH | New | LANTHEUS HLDGS INC | $11,888,900 | – | 180,053 | +100.0% | 0.84% | – |
| ALNY | Buy | ALNYLAM PHARMACEUTICALS INC | $11,520,254 | +33.4% | 78,987 | +49.4% | 0.82% | +23.5% |
| MASS | Buy | 908 DEVICES INC | $9,686,442 | +134.7% | 470,444 | +116.6% | 0.69% | +117.4% |
| LQDA | Buy | LIQUIDIA CORPORATION | $9,154,727 | -7.4% | 2,099,708 | +52.4% | 0.65% | -14.2% |
| QGEN | Sell | QIAGEN NV | $8,963,610 | -5.1% | 189,907 | -1.4% | 0.64% | -12.1% |
| IWM | New | ISHARES TRput | $8,468,000 | – | 50,000 | +100.0% | 0.60% | – |
| TARO | Buy | TARO PHARMACEUTICAL INDS LTD | $7,969,302 | -16.4% | 220,390 | +0.0% | 0.57% | -22.5% |
| HQY | Sell | HEALTHEQUITY INC | $7,799,170 | -19.8% | 127,043 | -11.9% | 0.55% | -25.7% |
| MRUS | Buy | MERUS N V | $6,515,928 | +220.7% | 287,806 | +274.5% | 0.46% | +196.8% |
| ILMN | Sell | ILLUMINA INC | $6,501,640 | -52.0% | 35,266 | -9.0% | 0.46% | -55.6% |
| HUM | New | HUMANA INC | $5,237,027 | – | 11,170 | +100.0% | 0.37% | – |
| RDUS | Buy | RADIUS HEALTH INC | $5,211,827 | +95.3% | 502,587 | +66.3% | 0.37% | +81.0% |
| VRDN | Buy | VIRIDIAN THERAPEUTICS INC | $5,155,499 | +79.0% | 445,592 | +186.1% | 0.37% | +66.1% |
| CLDX | New | CELLDEX THERAPEUTICS INC NEWcall | $5,165,536 | – | 191,600 | +100.0% | 0.37% | – |
| FOLD | New | AMICUS THERAPEUTICS INC | $5,136,351 | – | 478,245 | +100.0% | 0.36% | – |
| MRK | MERCK & CO INCcall | $4,439,979 | +11.1% | 48,700 | 0.0% | 0.32% | +2.9% | |
| PBYI | Buy | PUMA BIOTECHNOLOGY INC | $4,089,969 | -0.3% | 1,435,077 | +0.7% | 0.29% | -7.6% |
| GOSS | Buy | GOSSAMER BIO INC | $3,919,696 | +20.5% | 468,303 | +25.0% | 0.28% | +11.6% |
| ANAB | Buy | ANAPTYSBIO INC | $3,709,155 | +31.3% | 182,717 | +60.0% | 0.26% | +21.7% |
| ARKK | New | ARK ETF TRput | $3,589,200 | – | 90,000 | +100.0% | 0.26% | – |
| IONS | Sell | IONIS PHARMACEUTICALS INC | $3,195,233 | -45.7% | 86,311 | -45.7% | 0.23% | -49.8% |
| AFMD | New | AFFIMED N V | $3,132,208 | – | 1,130,761 | +100.0% | 0.22% | – |
| A | Buy | AGILENT TECHNOLOGIES INC | $2,406,755 | -5.5% | 20,264 | +5.2% | 0.17% | -12.8% |
| ISRG | Buy | INTUITIVE SURGICAL INC | $1,724,300 | -30.0% | 8,591 | +5.2% | 0.12% | -34.9% |
| CLDX | New | CELLDEX THERAPEUTICS INC NEWput | $1,633,776 | – | 60,600 | +100.0% | 0.12% | – |
| PKI | Buy | PERKINELMER INC | $1,463,870 | -14.3% | 10,293 | +5.2% | 0.10% | -20.6% |
| IQV | Sell | IQVIA HLDGS INC | $1,307,148 | -90.5% | 6,024 | -89.9% | 0.09% | -91.2% |
| LH | Sell | LABORATORY CORP AMER HLDGS | $1,254,763 | -87.4% | 5,354 | -85.9% | 0.09% | -88.4% |
| Sell | AADI BIOSCIENCE INC | $1,242,065 | -51.5% | 100,817 | -33.2% | 0.09% | -55.3% | |
| ICLR | Sell | ICON PLC | $1,210,703 | -89.4% | 5,587 | -88.1% | 0.09% | -90.2% |
| ZNTL | Sell | ZENTALIS PHARMACEUTICALS INC | $1,077,410 | -76.7% | 38,342 | -61.7% | 0.08% | -78.3% |
| DXCM | Sell | DEXCOM INC | $1,078,300 | -92.6% | 14,468 | -49.1% | 0.08% | -93.1% |
| RGEN | Sell | REPLIGEN CORP | $924,543 | -86.5% | 5,693 | -84.4% | 0.07% | -87.5% |
| MIST | MILESTONE PHARMACEUTICALS IN | $905,065 | -4.2% | 147,165 | 0.0% | 0.06% | -12.3% | |
| MASI | Sell | MASIMO CORP | $781,929 | -97.4% | 5,984 | -97.1% | 0.06% | -97.6% |
| CYH | New | COMMUNITY HEALTH SYS INC NEWcall | $750,000 | – | 200,000 | +100.0% | 0.05% | – |
| HSKA | Buy | HESKA CORP | $734,532 | -9.0% | 7,772 | +33.2% | 0.05% | -16.1% |
| TEVA | TEVA PHARMACEUTICAL INDS LTDcall | $698,608 | -19.9% | 92,900 | 0.0% | 0.05% | -25.4% | |
| SWAV | New | SHOCKWAVE MED INC | $630,861 | – | 3,300 | +100.0% | 0.04% | – |
| ACIU | AC IMMUNE SA | $449,766 | -9.8% | 124,589 | 0.0% | 0.03% | -15.8% | |
| CSU | SONIDA SENIOR LIVING INC | $319,389 | -36.6% | 15,209 | 0.0% | 0.02% | -41.0% | |
| ELDN | Sell | ELEDON PHARMACEUTICALS INC | $144,119 | -67.9% | 59,065 | -48.2% | 0.01% | -70.6% |
| BOLT | New | BOLT BIOTHERAPEUTICS INC | $63,591 | – | 31,172 | +100.0% | 0.01% | – |
| GLYC | GLYCOMIMETICS INC | $60,136 | -47.6% | 100,579 | 0.0% | 0.00% | -55.6% | |
| CLVS | Exit | CLOVIS ONCOLOGY INC | $0 | – | -30,000 | -100.0% | -0.01% | – |
| ORTX | Exit | ORCHARD THERAPEUTICS PLCads | $0 | – | -419,581 | -100.0% | -0.02% | – |
| AVRO | Exit | AVROBIO INC | $0 | – | -295,369 | -100.0% | -0.03% | – |
| CYCN | Exit | CYCLERION THERAPEUTICS INC | $0 | – | -371,955 | -100.0% | -0.03% | – |
| MREO | Exit | MEREO BIOPHARMA GROUP PLCads | $0 | – | -370,170 | -100.0% | -0.03% | – |
| IWO | Exit | ISHARES TRput | $0 | – | -1,700 | -100.0% | -0.03% | – |
| TECH | Exit | BIO-TECHNE CORP | $0 | – | -1,062 | -100.0% | -0.04% | – |
| SRGA | Exit | SURGALIGN HOLDINGS INC | $0 | – | -1,573,802 | -100.0% | -0.04% | – |
| ADAP | Exit | ADAPTIMMUNE THERAPEUTICS PLCsponds adr | $0 | – | -237,086 | -100.0% | -0.04% | – |
| SPRO | Exit | SPERO THERAPEUTICS INC | $0 | – | -59,639 | -100.0% | -0.04% | – |
| ASMB | Exit | ASSEMBLY BIOSCIENCES INC | $0 | – | -280,000 | -100.0% | -0.04% | – |
| KOD | Exit | KODIAK SCIENCES INC | $0 | – | -91,200 | -100.0% | -0.05% | – |
| ENSG | Exit | ENSIGN GROUP INC | $0 | – | -10,397 | -100.0% | -0.07% | – |
| KOD | Exit | KODIAK SCIENCES INCput | $0 | – | -181,200 | -100.0% | -0.11% | – |
| AUTL | Exit | AUTOLUS THERAPEUTICS PLCspon ads | $0 | – | -371,540 | -100.0% | -0.12% | – |
| MRK | Exit | MERCK & CO INC | $0 | – | -9,483 | -100.0% | -0.15% | – |
| KRTX | Exit | KARUNA THERAPEUTICS INC | $0 | – | -15,934 | -100.0% | -0.16% | – |
| PGNY | Exit | PROGYNY INCput | $0 | – | -50,000 | -100.0% | -0.20% | – |
| IRTC | Exit | IRHYTHM TECHNOLOGIES INC | $0 | – | -27,047 | -100.0% | -0.33% | – |
| EXEL | Exit | EXELIXIS INC | $0 | – | -203,156 | -100.0% | -0.35% | – |
| EWT | Exit | ISHARES INCput | $0 | – | -100,000 | -100.0% | -0.47% | – |
| SYNH | Exit | SYNEOS HEALTH INCcl a | $0 | – | -81,416 | -100.0% | -0.51% | – |
| OCDX | Exit | ORTHO CLINICAL DIAGNOSTICS H | $0 | – | -445,059 | -100.0% | -0.64% | – |
| NSTG | Exit | NANOSTRING TECHNOLOGIES INC | $0 | – | -280,695 | -100.0% | -0.75% | – |
| MCK | Exit | MCKESSON CORP | $0 | – | -52,375 | -100.0% | -1.23% | – |
| ARKG | Exit | ARK ETF TRgenomic rev etf | $0 | – | -470,506 | -100.0% | -1.66% | – |
| HCA | Exit | HCA HEALTHCARE INC | $0 | – | -111,440 | -100.0% | -2.14% | – |
| BIIB | Exit | BIOGEN INCcall | $0 | – | -140,000 | -100.0% | -2.26% | – |
| RCM | Exit | R1 RCM INC | $0 | – | -1,361,506 | -100.0% | -2.80% | – |
| ASND | Exit | ASCENDIS PHARMA A/Ssponsored adr | $0 | – | -417,172 | -100.0% | -3.76% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AMARIN CORP PLC | 21 | Q3 2023 | 12.5% |
| DANAHER CORPORATION | 21 | Q3 2023 | 8.1% |
| AFFIMED N V | 20 | Q3 2023 | 0.9% |
| ARGENX SE | 19 | Q3 2023 | 2.0% |
| GSK PLC | 18 | Q2 2022 | 13.1% |
| ASCENDIS PHARMA A/S | 18 | Q1 2022 | 7.7% |
| SANOFI | 18 | Q4 2022 | 7.2% |
| ENSIGN GROUP INC | 18 | Q1 2022 | 8.6% |
| CENTENE CORP DEL | 18 | Q3 2023 | 1.5% |
| ZOGENIX INC | 17 | Q4 2021 | 12.4% |
View Eversept Partners, LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Cabaletta Bio, Inc. | February 14, 2023 | 282,874 | 1.0% |
| Teligent, Inc.Sold out | February 16, 2021 | 0 | 0.0% |
| Teligent, Inc. | February 14, 2020 | 4,501,799 | 8.4% |
View Eversept Partners, LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
View Eversept Partners, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.